GENE ONLINE|News &
Opinion
Blog

Spotlight: New Gene Therapies on the Horizon for the Treatment of Neurogenetic Diseases

by GeneOnline
Share To
Gene therapies have dramatically altered the landscape of neurological disease treatments, with the USFDA expecting to review 10 to 20 cell and gene therapies each year by 2025. Over 1000 gene therapy studies are currently underway for neurological diseases. Here, we attempted to review the field. Although the genetic basis underlying common neurological and neuromuscular disorders

GO Prime with only $1.49 now

LATEST
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
2024-04-12
Vertex Pharmaceuticals Makes $4.9 Billion Bet on Kidney Disease Treatment through Alpine Immune Acquisition
2024-04-11
Bayer Signs New Partnership with Google Cloud, Joining Hands for AI Solutions for Radiologists
2024-04-10
Pharmacogenomics (PGx) Shaping the Dynamic APAC Regions
2024-04-10
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
2024-04-10
Innovating Prostate Cancer Care: SYNC-T, Proteogenomics, and Culturally Tailored Education at AACR 2024
2024-04-10
EVENT
Scroll to Top